ABOUT IPSEN

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. Our oncology work focuses on solid tumors and some of the hardest-to-treat cancers. We have a growing portfolio of therapies aimed at improving the lives of patients with gastrointestinal and pancreatic neuroendocrine tumors, carcinoid syndrome, and pancreatic cancer. Every day, our more than 5,700 employees worldwide, including over 600 in North America, work diligently to improve the lives of patients around the world.

For more information please visit www.ipsenus.com.

PATIENT BROCHURES

OTHER RESOURCES

Click here to download the SOMATULINE® DEPOTprescribing information packet.

SOMATULINE® DEPOT Website

IPSEN Cares Website

Contact an Ipsen Representative

Alice Donnelly

Manager, Portfolio Communications

Email: alice.donnelly@ipsen.com

Phone: (973) 936-4697

This information is for educational purposes only and does not substitute for medical advice or constitute an endorsement by the Neuroendocrine Cancer Foundation. Talk to your medical team about your individual care and treatment.